SCHEMBL12372070

SCHEMBL12372070

CCOC(=O)c1cn(C)c2cc(/C=N/c3nccn3C(c3ccccc3)(c3ccccc3)c3ccccc3)ccc2c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.37
IRAK1 P51617 1/20 0.37
CAMK2B Q13554 1/20 0.37
CAMK2G Q13555 1/20 0.37
CAMK2D Q13557 1/20 0.37
PIM3 Q86V86 1/20 0.37
P2RX3 P56373 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
ROCK2 O75116 1/20 0.35
CDK1 P06493 1/20 0.35
PRKACA P17612 1/20 0.35
CDK2 P24941 1/20 0.35
CSNK1D P48730 1/20 0.35
GSK3A P49840 1/20 0.35
CDK5 Q00535 1/20 0.35
PRKCD Q05655 1/20 0.35
ROCK1 Q13464 1/20 0.35
CDC42BPA Q5VT25 1/20 0.35
MARK2 Q7KZI7 1/20 0.35
KDM4E B2RXH2 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12398872 0.81 P2RX3 (0.38) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL12372084 0.78 P2RX3 (0.42) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL2279745 0.73 LMNA (0.47) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL5777913 0.72 KMT2A (0.49) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL5779683 0.71 S1PR1 (0.36) P2RX3ALDH1A1LMNANPC1RAB9A
SCHEMBL10341167 0.69 LMNA (0.47) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL2998174 0.69 MAP2K2 (0.52) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL2276835 0.68 P2RX3 (0.40) PIM1IRAK1CAMK2BCAMK2GCAMK2D
SCHEMBL15071685 0.68 ALDH1A1 (0.57) TDP1KDM4ENPSR1PKMALDH1A1
SCHEMBL10341236 0.68 LMNA (0.49) PIM1IRAK1CAMK2BCAMK2GCAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998462-B2 Linkers for anchoring targeting ligands KEREOS, INC. (US) 2011-08-16 US disclosed
US-7998462-B2 Linkers for anchoring targeting ligands KEREOS, INC. (US) 2011-08-16 US disclosed
US-20080305037-A1 LINKERS FOR ANCHORING TARGETING LIGANDS KEREOS, INC. 2008-12-11 US disclosed
US-20080305037-A1 LINKERS FOR ANCHORING TARGETING LIGANDS KEREOS, INC. 2008-12-11 US disclosed
WO-2008070291-A2 IMPROVED LINKERS FOR ANCHORING TARGETING LIGANDS KEREOS, INC. (US) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305037-A1 LINKERS FOR ANCHORING TARGETING LIGANDS LDLR, HDLBP, FABP1 PIM1 2365/4885IRAK1 3853/4885CAMK2B 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.